Cabaletta Bio, Inc. · NASDAQ:CABA
Vanguard Capital Management LLC reported a 5.08% stake in Cabaletta Bio, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.08% stake in Cabaletta Bio, Inc., 8,295,783 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.08%
- Shares
- 8,295,783
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.08% | 8,295,783 |
Source
Related
- Cabaletta Bio, Inc.
- Vanguard Capital Management LLC
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026